Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10968594 | Vaccine | 2011 | 7 Pages |
Abstract
⺠Pneumococcal disease continues to cause substantial morbidity and mortality throughout the world. ⺠We describe the epidemiology of blood culture positive S. pneumoniae community-acquired pneumonia (CAP) in a hospital cohort from the Northern Territory of Australia. ⺠In this cohort, males and Indigenous patients were over represented. ⺠There was no decline in disease incidence following the introduction of the 23-valent pneumococcal polysaccharide vaccine. ⺠Consumption of alcohol to excess, diabetes, age greater than 45, Indigenous status and smoking are independent risk factors for S. pneumoniae CAP.
Keywords
CLDRoyal Darwin HospitalRDH23vPPVCXRIPDCRDGLMAustraliachest X-raySocioeconomicEpidemiologyintensive care unitICUIndigenousChronic lung diseasechronic renal diseaseInvasive pneumococcal diseaseRelative riskPneumoniaRisk factorsconfidence intervalPovertyNorthern TerritoryGeneralized linear modelProspective studiesIncidence rates7-valent pneumococcal conjugate vaccine23-Valent pneumococcal polysaccharide vaccinePneumococcal vaccinesTropical medicineCommunity-acquired pneumoniaCaP
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Susan P. Jacups, Allen Cheng,